Washington, DC — Speaking at a conference today, a senior White House official claimed House Democrats’ landmark bill giving Medicare the power to negotiate for lower drug prices is “unworkable” and “hyper-partisan.” In a recent poll by Hart Research for Protect Our Care, 77% of Americans, including 54% of Republicans supported giving Medicare the power to negotiate for lower drug prices for all Americans. In response, Protect Our Care Executive Director Brad Woodhouse released the following statement:
“The only ones being ‘hyper-partisan’ in the debate over lowering drug prices are President Trump and his Republican allies who continue to put big pharma profits over patients. The American people overwhelmingly support the measures put forward in the House Democrats’ bill to lower drug costs, including giving Medicare the power to negotiate for lower drug prices, and reining in drug and insurance companies. It’s clear to the American people that the Trump administration hasn’t lifted a finger to tackle prescription drug costs. Their failure to even consider the effective and popular measures in the House bill proves the Trump administration has no interest in making progress or solving this problem.”
BACKGROUND:
Recent national polling from Hart Research Associates for Protect Our Care of 1,000 voters confirms the provisions of H.R. 3 are supported by the majority of Americans across the political spectrum.
- 77% of Americans support giving Medicare the power to negotiate for lower drug prices for all consumers.
- 77% of Americans support Democrats’ proposal to use the savings Medicare would achieve by negotiating for lower drug prices to provide vision, dental and hearing benefits for seniors.
- 97% of Americans support the H.R. 3 provision preventing drug companies from charging Americans more for the same drug than they charge people in other countries.